Midcap funds had a quiet 2026, with the Nifty Midcap 150 TRI up only 2.4%. However, active managers got good results, as 26 of 31 funds beat the benchmark. HSBC Midcap Fund led the pack with a 16.83% return as of 13 November 2026, showing many funds still performed well.

Midcap funds have had a quiet 2026. The Nifty Midcap 150 TRI is up only 2.4% this year. Of the 31 midcap funds with a 2026 return, the average one gave about 5.8%.

Still, active managers have added something. 26 of the 31 funds have beaten the Nifty Midcap 150 TRI, and six have returned 10% or more.

The best of them, HSBC Midcap Fund, has returned 16.8%.

Here are the five best performing midcap mutual funds of 2026 so far, ranked by returns as of 13 November 2026.

#1 HSBC Midcap Fund

First on the list is HSBC Midcap Fund.

The fund has returned 16.83% so far in 2026, which is 14.4 percentage points (pp) more than the Nifty Midcap 150 TRI at 2.44%. Its NAV is Rs 470.25.

It is the largest fund on the list, with about Rs 168 bn in assets, and is run by Cheenu Gupta (since November 2022) and Mayank Chaturvedi (since October 2025).

The direct plan has returned 22.3% a year over three years and 18.1% over five years, against 14.0% and 13.7% for the benchmark.

About 66% of the portfolio is in midcaps and 24% in small caps. Financial services (32.7%) and industrials (29.9%) are the largest sectors, followed by healthcare at 10%.

Its top stocks at the end of October were Meesho (5.2%), Lenskart (5.0%), The Federal Bank (4.7%), Coforge (4.1%) and Zydus Lifesciences (3.8%). Its portfolio turnover is about 112%.

Overall, HSBC has a long record of beating its benchmark, and 2026 is another strong year. But do remember that about a quarter of the fund is in small caps, which adds to its risk.

#2 Bandhan Midcap Fund

Next on the list is Bandhan Midcap Fund.

The fund has returned 12.04% in 2026 so far, which is 9.6 pp more than the Nifty Midcap 150 TRI. Its NAV is Rs 19.39.

It manages about Rs 25.2 bn. Ritika Behera leads the fund, along with Gaurav Satra, Harshal Joshi and Ritu Modi.

Over three years it has returned about 16.6% a year, and over the last year about 8.3%.

The portfolio has about 89 stocks and is spread across sectors, with financials, consumer, healthcare, industrials and technology each at roughly 13% to 17%.

Its top stocks include Apar Industries (3.6%), The Federal Bank (3.2%), GE T&D India (3.0%), Ipca Laboratories (2.7%) and Persistent Systems (2.5%).

Overall, Bandhan is a well-spread fund with no single stock above 4%.

#3 JM Midcap Fund

Third on the list is JM Midcap Fund.

The fund has returned 10.99% in 2026, which is 8.5 pp more than the Nifty Midcap 150 TRI. Its NAV is Rs 21.09.

It is the smallest of the five funds on this list, with about Rs 13.0 bn in assets. The managers are Ruchi Fozdar, Satish Ramanathan, Deepak Gupta and Asit Bhandarkar.

Over three years it has returned about 16.4% a year, against a category average of 14.6%.

The fund has about 74 stocks. The top ones are One 97 Communications (3.6%), Avalon Technologies (3.1%), Mankind Pharma (2.9%), Godfrey Phillips India (2.9%) and IDFC First Bank (2.8%).

Financials are about 22% of the portfolio and industrials about 19%.

Overall, JM has a more unusual portfolio than the others, with little overlap in its top stocks, and a small asset base.

#4 Invesco India Midcap Fund

Fourth on the list is Invesco India Midcap Fund.

The fund has returned 10.52% in 2026, which is 8.1 pp more than the Nifty Midcap 150 TRI. Its NAV is Rs 202.73.

It is the second largest fund here, with about Rs 158 bn in assets, and is run by Aditya Khemani, who has managed it since November 2023.

Over three years it has returned about 22.7% a year, and over five years about 17.3%.

The portfolio is concentrated. Its top five stocks make up about 30%: Prestige Estates Projects (7.3%), Max Healthcare Institute (7.2%), Meesho (5.4%), The Federal Bank (5.4%) and Manipal Health Enterprises (4.4%).

Financials and healthcare are each roughly a quarter of the portfolio.

Overall, Invesco has a strong three and five-year record, but with a concentrated portfolio, its returns will depend on a small number of stocks.

#5 WOC Mid Cap Fund

Last on the list is WOC Mid Cap Fund, formerly WhiteOak Capital Mid Cap Fund.

The fund has returned 10.29% in 2026, which is 7.8 pp more than the Nifty Midcap 150 TRI. Its NAV is Rs 22.12.

It manages about Rs 77.9 bn and has a team of five managers: Ramesh Mantri, Piyush Baranwal, Trupti Agrawal, Dheeresh Pathak and Ashish Agrawal.

Over three years it has returned about 19.5% a year, and its one-year return of about 9.0% is above the category average of 3.7%.

This is the most spread-out portfolio of the five, with about 171 stocks. Cash is the largest position at 6.8%, and the top stocks are Bharti Hexacom (2.5%), Coforge (2.5%), The Federal Bank (2.2%) and Max Financial Services (2.2%).

Overall, WOC has the widest portfolio and a good three-year record, and the high cash level means part of the fund is not invested in stocks.

How All Funds Compare

Here is how the five funds compare:

Data Source: Ace MF, as of 13 November

Conclusion

Midcap funds can be a strong addition for long-term investors.

They typically offer higher growth potential than large caps because these companies are still expanding their market share, scaling operations, and benefiting from sectoral tailwinds.

However, this upside comes with higher volatility and sharper drawdowns during market corrections.

Going forward, midcaps tend to perform well when earnings growth is broad-based and liquidity in the market is supportive, but they can underperform during risk-off phases or macro uncertainty.

Also, midcap funds are rated Very High risk, and a good ten months does not guarantee the next year.

Investors should evaluate the fund's portfolio, costs, fund manager and fit with their own goals before drawing any investment conclusions.

The website managers, its employee(s), and contributors/writers/authors of articles have or may have an outstanding buy or sell position or holding in the securities, options on securities or other related investments of issuers and/or companies discussed therein. The content of the articles and the interpretation of data are solely the personal views of the contributors/ writers/authors. Investors must make their own investment decisions based on their specific objectives, resources and only after consulting such independent advisors as may be necessary